Director's Shareholding Updat

RNS Number : 4665J

Epistem Holdings plc

01 April 2010

 

For release: 1 April 2010

Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors have each increased their beneficial interest in the Company by 249 ordinary shares of 1.5p each. These shares were acquired in tranches at the end of January, February and March 2010 at prices of 445p, 442p and 447p respectively.

The current beneficial interests of the executive Directors are set out below:

Matthew Walls                             6,901                                   (0.08%)

Dr Catherine Booth                  981,256                                  (12.37%)

Dr Ged Brady                              1,256                                   (0.02%)

Dr Jeffrey Moore                        15,756                                   (0.20%)          

John Rylands                            191,154                                   (2.41%)

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

KBC Peel Hunt Ltd.

James Steel / Vijay Barathan                                                     [phone]

 

END

 

 

RDSJMMFTMBAJBJM